The Diagnostic Capacity of Three Phenotypic Techniques of Extended-Spectrum β-Lactamase Detection
Background: Early detection of extended-spectrum β-lactamases (ESBLs) producing bacteria is critical for infection prevention and control. Numerous phenotypic approaches and automated systems have been developed for detecting ESBL bacteria. However, there is a scarcity of data in Ethiopia regarding...
Gespeichert in:
Veröffentlicht in: | Avicenna journal of clinical microbiology and infection: AJCMI 2022-03, Vol.9 (1), p.1-7 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 7 |
---|---|
container_issue | 1 |
container_start_page | 1 |
container_title | Avicenna journal of clinical microbiology and infection: AJCMI |
container_volume | 9 |
creator | Abdeta, Abera Bitew, Adane Fentaw, Surafel Tsige, Estifanos Assefa, Dawit Tigabu, Eyasu Lejisa, Tadesse Kefyalew, Yordanos Fekede, Ebisa |
description | Background: Early detection of extended-spectrum β-lactamases (ESBLs) producing bacteria is critical for infection prevention and control. Numerous phenotypic approaches and automated systems have been developed for detecting ESBL bacteria. However, there is a scarcity of data in Ethiopia regarding the most reliable, simple, and cost-effective methods for detecting ESBL-producing bacteria. This study, therefore, aimed to evaluate the diagnostic performance of three phenotypic approaches for detecting ESBL-producing bacteria. Methods: In this study, 117 isolates of Klebsiella pneumoniae, Escherichia coli, Klebsiella oxytoca, and Proteus mirabilis were examined. Cefotaxime (30 µg) and ceftazidime (30 µg) were used for screening ESBL enzymes. A screening breakpoints of≤27 mm and≤22 mm were used for cefotaxime (30 µg) and ceftazidime (30 µg), respectively, as per the Clinical and Laboratory Standards Institute (CLSI) guidelines. All 117 strains were further confirmed by the Vitek 2 compact, double disk synergy, ESBL Epsilometer test, and combined disk method. The combined disk method was adopted as the reference method. Results: Out of 117 isolates, 90 (86%) had zone diameters of≤27 mm and≤22 mm for cefotaxime (30 µg) and ceftazidime (30 µg), respectively. The reference method detected 76 (65%) ESBL isolates out of 117 ones. From among the three techniques (i.e., double disk synergy, Vitek 2 compact, and ESBL Epsilometer test), the double disk synergy method demonstrated overall sensitivity and specificity of 97.4% and 97.6%, respectively. Vitek-2, cefotaxime, and ceftazidime Epsilometer test indicated indeterminate results of 6.8%, 6.8%, and 5.1% respectively. Conclusion: Double disk synergy was found to have the highest sensitivity and specificity for detecting ESBL isolates with no indeterminate results. |
doi_str_mv | 10.34172/ajcmi.2022.01 |
format | Article |
fullrecord | <record><control><sourceid>crossref</sourceid><recordid>TN_cdi_crossref_primary_10_34172_ajcmi_2022_01</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_34172_ajcmi_2022_01</sourcerecordid><originalsourceid>FETCH-LOGICAL-c791-cbcbeb1c776381b41fcd749d9ccee4c23e439d11f4755ac984d1e99d63e527ec3</originalsourceid><addsrcrecordid>eNo1kEtOwzAURS0EElXplHE2kOBnOx8PUSkfqRJIZB45zy_EFfkQuxLZFgthTbQFRvfqHukODmPXwBOpIBc3ZoedSwQXIuFwxhZCFjLmksP5fxe6uGQr73ecc0iLTGfFgtVlS9GdM2_94IPDaG1Ggy7M0dBEZTsRRS8t9UOYxwMsCdvefezJH_HmM1BvycavI2GY9l30_RVvDQbTGX84pXCY3dBfsYvGvHta_eWSlfebcv0Yb58fnta32xhzDTHWWFMNmOeZLKBW0KDNlbYakUihkKSktgCNytPUoC6UBdLaZpJSkRPKJUt-b3EavJ-oqcbJdWaaK-DVyVF1clQdHVUc5A--Zl0k</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>The Diagnostic Capacity of Three Phenotypic Techniques of Extended-Spectrum β-Lactamase Detection</title><source>EZB-FREE-00999 freely available EZB journals</source><creator>Abdeta, Abera ; Bitew, Adane ; Fentaw, Surafel ; Tsige, Estifanos ; Assefa, Dawit ; Tigabu, Eyasu ; Lejisa, Tadesse ; Kefyalew, Yordanos ; Fekede, Ebisa</creator><creatorcontrib>Abdeta, Abera ; Bitew, Adane ; Fentaw, Surafel ; Tsige, Estifanos ; Assefa, Dawit ; Tigabu, Eyasu ; Lejisa, Tadesse ; Kefyalew, Yordanos ; Fekede, Ebisa</creatorcontrib><description>Background: Early detection of extended-spectrum β-lactamases (ESBLs) producing bacteria is critical for infection prevention and control. Numerous phenotypic approaches and automated systems have been developed for detecting ESBL bacteria. However, there is a scarcity of data in Ethiopia regarding the most reliable, simple, and cost-effective methods for detecting ESBL-producing bacteria. This study, therefore, aimed to evaluate the diagnostic performance of three phenotypic approaches for detecting ESBL-producing bacteria. Methods: In this study, 117 isolates of Klebsiella pneumoniae, Escherichia coli, Klebsiella oxytoca, and Proteus mirabilis were examined. Cefotaxime (30 µg) and ceftazidime (30 µg) were used for screening ESBL enzymes. A screening breakpoints of≤27 mm and≤22 mm were used for cefotaxime (30 µg) and ceftazidime (30 µg), respectively, as per the Clinical and Laboratory Standards Institute (CLSI) guidelines. All 117 strains were further confirmed by the Vitek 2 compact, double disk synergy, ESBL Epsilometer test, and combined disk method. The combined disk method was adopted as the reference method. Results: Out of 117 isolates, 90 (86%) had zone diameters of≤27 mm and≤22 mm for cefotaxime (30 µg) and ceftazidime (30 µg), respectively. The reference method detected 76 (65%) ESBL isolates out of 117 ones. From among the three techniques (i.e., double disk synergy, Vitek 2 compact, and ESBL Epsilometer test), the double disk synergy method demonstrated overall sensitivity and specificity of 97.4% and 97.6%, respectively. Vitek-2, cefotaxime, and ceftazidime Epsilometer test indicated indeterminate results of 6.8%, 6.8%, and 5.1% respectively. Conclusion: Double disk synergy was found to have the highest sensitivity and specificity for detecting ESBL isolates with no indeterminate results.</description><identifier>ISSN: 2383-0298</identifier><identifier>EISSN: 2383-0301</identifier><identifier>DOI: 10.34172/ajcmi.2022.01</identifier><language>eng</language><ispartof>Avicenna journal of clinical microbiology and infection: AJCMI, 2022-03, Vol.9 (1), p.1-7</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><orcidid>0000-0003-2252-6049</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Abdeta, Abera</creatorcontrib><creatorcontrib>Bitew, Adane</creatorcontrib><creatorcontrib>Fentaw, Surafel</creatorcontrib><creatorcontrib>Tsige, Estifanos</creatorcontrib><creatorcontrib>Assefa, Dawit</creatorcontrib><creatorcontrib>Tigabu, Eyasu</creatorcontrib><creatorcontrib>Lejisa, Tadesse</creatorcontrib><creatorcontrib>Kefyalew, Yordanos</creatorcontrib><creatorcontrib>Fekede, Ebisa</creatorcontrib><title>The Diagnostic Capacity of Three Phenotypic Techniques of Extended-Spectrum β-Lactamase Detection</title><title>Avicenna journal of clinical microbiology and infection: AJCMI</title><description>Background: Early detection of extended-spectrum β-lactamases (ESBLs) producing bacteria is critical for infection prevention and control. Numerous phenotypic approaches and automated systems have been developed for detecting ESBL bacteria. However, there is a scarcity of data in Ethiopia regarding the most reliable, simple, and cost-effective methods for detecting ESBL-producing bacteria. This study, therefore, aimed to evaluate the diagnostic performance of three phenotypic approaches for detecting ESBL-producing bacteria. Methods: In this study, 117 isolates of Klebsiella pneumoniae, Escherichia coli, Klebsiella oxytoca, and Proteus mirabilis were examined. Cefotaxime (30 µg) and ceftazidime (30 µg) were used for screening ESBL enzymes. A screening breakpoints of≤27 mm and≤22 mm were used for cefotaxime (30 µg) and ceftazidime (30 µg), respectively, as per the Clinical and Laboratory Standards Institute (CLSI) guidelines. All 117 strains were further confirmed by the Vitek 2 compact, double disk synergy, ESBL Epsilometer test, and combined disk method. The combined disk method was adopted as the reference method. Results: Out of 117 isolates, 90 (86%) had zone diameters of≤27 mm and≤22 mm for cefotaxime (30 µg) and ceftazidime (30 µg), respectively. The reference method detected 76 (65%) ESBL isolates out of 117 ones. From among the three techniques (i.e., double disk synergy, Vitek 2 compact, and ESBL Epsilometer test), the double disk synergy method demonstrated overall sensitivity and specificity of 97.4% and 97.6%, respectively. Vitek-2, cefotaxime, and ceftazidime Epsilometer test indicated indeterminate results of 6.8%, 6.8%, and 5.1% respectively. Conclusion: Double disk synergy was found to have the highest sensitivity and specificity for detecting ESBL isolates with no indeterminate results.</description><issn>2383-0298</issn><issn>2383-0301</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNo1kEtOwzAURS0EElXplHE2kOBnOx8PUSkfqRJIZB45zy_EFfkQuxLZFgthTbQFRvfqHukODmPXwBOpIBc3ZoedSwQXIuFwxhZCFjLmksP5fxe6uGQr73ecc0iLTGfFgtVlS9GdM2_94IPDaG1Ggy7M0dBEZTsRRS8t9UOYxwMsCdvefezJH_HmM1BvycavI2GY9l30_RVvDQbTGX84pXCY3dBfsYvGvHta_eWSlfebcv0Yb58fnta32xhzDTHWWFMNmOeZLKBW0KDNlbYakUihkKSktgCNytPUoC6UBdLaZpJSkRPKJUt-b3EavJ-oqcbJdWaaK-DVyVF1clQdHVUc5A--Zl0k</recordid><startdate>20220329</startdate><enddate>20220329</enddate><creator>Abdeta, Abera</creator><creator>Bitew, Adane</creator><creator>Fentaw, Surafel</creator><creator>Tsige, Estifanos</creator><creator>Assefa, Dawit</creator><creator>Tigabu, Eyasu</creator><creator>Lejisa, Tadesse</creator><creator>Kefyalew, Yordanos</creator><creator>Fekede, Ebisa</creator><scope>AAYXX</scope><scope>CITATION</scope><orcidid>https://orcid.org/0000-0003-2252-6049</orcidid></search><sort><creationdate>20220329</creationdate><title>The Diagnostic Capacity of Three Phenotypic Techniques of Extended-Spectrum β-Lactamase Detection</title><author>Abdeta, Abera ; Bitew, Adane ; Fentaw, Surafel ; Tsige, Estifanos ; Assefa, Dawit ; Tigabu, Eyasu ; Lejisa, Tadesse ; Kefyalew, Yordanos ; Fekede, Ebisa</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c791-cbcbeb1c776381b41fcd749d9ccee4c23e439d11f4755ac984d1e99d63e527ec3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Abdeta, Abera</creatorcontrib><creatorcontrib>Bitew, Adane</creatorcontrib><creatorcontrib>Fentaw, Surafel</creatorcontrib><creatorcontrib>Tsige, Estifanos</creatorcontrib><creatorcontrib>Assefa, Dawit</creatorcontrib><creatorcontrib>Tigabu, Eyasu</creatorcontrib><creatorcontrib>Lejisa, Tadesse</creatorcontrib><creatorcontrib>Kefyalew, Yordanos</creatorcontrib><creatorcontrib>Fekede, Ebisa</creatorcontrib><collection>CrossRef</collection><jtitle>Avicenna journal of clinical microbiology and infection: AJCMI</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Abdeta, Abera</au><au>Bitew, Adane</au><au>Fentaw, Surafel</au><au>Tsige, Estifanos</au><au>Assefa, Dawit</au><au>Tigabu, Eyasu</au><au>Lejisa, Tadesse</au><au>Kefyalew, Yordanos</au><au>Fekede, Ebisa</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Diagnostic Capacity of Three Phenotypic Techniques of Extended-Spectrum β-Lactamase Detection</atitle><jtitle>Avicenna journal of clinical microbiology and infection: AJCMI</jtitle><date>2022-03-29</date><risdate>2022</risdate><volume>9</volume><issue>1</issue><spage>1</spage><epage>7</epage><pages>1-7</pages><issn>2383-0298</issn><eissn>2383-0301</eissn><abstract>Background: Early detection of extended-spectrum β-lactamases (ESBLs) producing bacteria is critical for infection prevention and control. Numerous phenotypic approaches and automated systems have been developed for detecting ESBL bacteria. However, there is a scarcity of data in Ethiopia regarding the most reliable, simple, and cost-effective methods for detecting ESBL-producing bacteria. This study, therefore, aimed to evaluate the diagnostic performance of three phenotypic approaches for detecting ESBL-producing bacteria. Methods: In this study, 117 isolates of Klebsiella pneumoniae, Escherichia coli, Klebsiella oxytoca, and Proteus mirabilis were examined. Cefotaxime (30 µg) and ceftazidime (30 µg) were used for screening ESBL enzymes. A screening breakpoints of≤27 mm and≤22 mm were used for cefotaxime (30 µg) and ceftazidime (30 µg), respectively, as per the Clinical and Laboratory Standards Institute (CLSI) guidelines. All 117 strains were further confirmed by the Vitek 2 compact, double disk synergy, ESBL Epsilometer test, and combined disk method. The combined disk method was adopted as the reference method. Results: Out of 117 isolates, 90 (86%) had zone diameters of≤27 mm and≤22 mm for cefotaxime (30 µg) and ceftazidime (30 µg), respectively. The reference method detected 76 (65%) ESBL isolates out of 117 ones. From among the three techniques (i.e., double disk synergy, Vitek 2 compact, and ESBL Epsilometer test), the double disk synergy method demonstrated overall sensitivity and specificity of 97.4% and 97.6%, respectively. Vitek-2, cefotaxime, and ceftazidime Epsilometer test indicated indeterminate results of 6.8%, 6.8%, and 5.1% respectively. Conclusion: Double disk synergy was found to have the highest sensitivity and specificity for detecting ESBL isolates with no indeterminate results.</abstract><doi>10.34172/ajcmi.2022.01</doi><tpages>7</tpages><orcidid>https://orcid.org/0000-0003-2252-6049</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2383-0298 |
ispartof | Avicenna journal of clinical microbiology and infection: AJCMI, 2022-03, Vol.9 (1), p.1-7 |
issn | 2383-0298 2383-0301 |
language | eng |
recordid | cdi_crossref_primary_10_34172_ajcmi_2022_01 |
source | EZB-FREE-00999 freely available EZB journals |
title | The Diagnostic Capacity of Three Phenotypic Techniques of Extended-Spectrum β-Lactamase Detection |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T07%3A45%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Diagnostic%20Capacity%20of%20Three%20Phenotypic%20Techniques%20of%20Extended-Spectrum%20%CE%B2-Lactamase%20Detection&rft.jtitle=Avicenna%20journal%20of%20clinical%20microbiology%20and%20infection:%20AJCMI&rft.au=Abdeta,%20Abera&rft.date=2022-03-29&rft.volume=9&rft.issue=1&rft.spage=1&rft.epage=7&rft.pages=1-7&rft.issn=2383-0298&rft.eissn=2383-0301&rft_id=info:doi/10.34172/ajcmi.2022.01&rft_dat=%3Ccrossref%3E10_34172_ajcmi_2022_01%3C/crossref%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |